Portable Cooling Device Maintains Vaccine Viability
By HospiMedica International staff writers Posted on 28 Sep 2016 |
Image: The Isobar device can be used to transport vaccines in developing countries (Photo courtesy of William Broadway).
A new portable cooling device that can keep vaccines cold for up to six days and can be recharged in just over an hour can improve vaccine transportation in developing countries.
The Isobar device, developed by Loughborough University (United Kingdom) graduate William Broadway as part of his final year project, uses a chemical refrigeration process invented by Dr. Albert Einstein in 1906 to maintain stable temperature control (2-8 ˚C) for up to 30 days. The core principal of the technology relies upon heat to separate ammonia from a two-phase mix of ammonia and water into an upper chamber. When needed, a valve is opened to let the ammonia evaporate into the original chamber, giving a powerful cooling effect.
The key innovation of the Isobar lies in the way the effect is controlled and recharged. It is controlled using an automated valve that monitors the internal temperature of the insulated vaccine backpack, and recharged using either an internal electric heating element or with an external propane burner. The simplicity of the system allows it to be adapted to logistical problems such as transport, or infrastructure breakdowns that could lead to the vaccines loosing potency. The Isobar has been announced as the UK winner of the 2016 James Dyson design award.
“I used the maximum load carriage for how many vaccines a small women from India can carry to design a 1.6 liter unit that is capable of delivering 2,460 0.5ml doses of vaccine over six days, without the need to recharge,” said inventor William Broadway. “It can be sustainably recharged in an hour using a 900w heating element for day-to-day use, and a propane burner that can be recharged on-the-go in case of emergency for up to 30-days. The propane burner and pressure unit was designed to limit the energy input to meet international safety standards.”
The principal application of technology was developed by hobbyists in 1929 into a commercial cooling unit called the Icyball. Since then the technology has been widely forgotten, due to the introduction of electric refrigerators. But since absorption refrigeration requires no fans, pumps, or any moving parts to work, original Icyball units from that time are still working, 85 years after their introduction.
Related Links:
Loughborough University
The Isobar device, developed by Loughborough University (United Kingdom) graduate William Broadway as part of his final year project, uses a chemical refrigeration process invented by Dr. Albert Einstein in 1906 to maintain stable temperature control (2-8 ˚C) for up to 30 days. The core principal of the technology relies upon heat to separate ammonia from a two-phase mix of ammonia and water into an upper chamber. When needed, a valve is opened to let the ammonia evaporate into the original chamber, giving a powerful cooling effect.
The key innovation of the Isobar lies in the way the effect is controlled and recharged. It is controlled using an automated valve that monitors the internal temperature of the insulated vaccine backpack, and recharged using either an internal electric heating element or with an external propane burner. The simplicity of the system allows it to be adapted to logistical problems such as transport, or infrastructure breakdowns that could lead to the vaccines loosing potency. The Isobar has been announced as the UK winner of the 2016 James Dyson design award.
“I used the maximum load carriage for how many vaccines a small women from India can carry to design a 1.6 liter unit that is capable of delivering 2,460 0.5ml doses of vaccine over six days, without the need to recharge,” said inventor William Broadway. “It can be sustainably recharged in an hour using a 900w heating element for day-to-day use, and a propane burner that can be recharged on-the-go in case of emergency for up to 30-days. The propane burner and pressure unit was designed to limit the energy input to meet international safety standards.”
The principal application of technology was developed by hobbyists in 1929 into a commercial cooling unit called the Icyball. Since then the technology has been widely forgotten, due to the introduction of electric refrigerators. But since absorption refrigeration requires no fans, pumps, or any moving parts to work, original Icyball units from that time are still working, 85 years after their introduction.
Related Links:
Loughborough University
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure